The neuroendocrine control of glucose allocation

Experimental and Clinical Endocrinology and Diabetes

Volumn 110, Issue 5, 2002, Pages 199-211

  Peters, Achim ^a   Schweiger, U ^a   Fruhwald Schultes B ^a   Born, J ^a   Fehm, H ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Blood brain barrier; Brain; Glucose; Mathematical model; Metabolic syndrome

Indexed keywords

GLUCOSE TRANSPORTER 4; LEPTIN; GLUCOSE;

BLOOD BRAIN BARRIER; DYSLIPIDEMIA; FEEDBACK SYSTEM; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT SYSTEM; HYPERGLYCEMIA; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN RESISTANCE; LIPID STORAGE; MATHEMATICAL MODEL; NEUROENDOCRINE SYSTEM; NEUROENDOCRINOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; REVIEW; WEIGHT GAIN; ANIMAL; BIOLOGICAL MODEL; HOMEOSTASIS; HUMAN; METABOLISM; NEUROSECRETION; PHYSIOLOGY;

ANIMAL; GLUCOSE; HOMEOSTASIS; HUMAN; MODELS, BIOLOGICAL; NEUROSECRETORY SYSTEMS; ANIMALS; HUMANS;

EID: 0036024159     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-33068     Document Type: Review

References (165)

1. Cloning of the beta cell high-affinity sulfonylurea receptor: A regulator of insulng secretion
2. Distinct physiologic and neuronal responses to decreased leptin and mild hyperleptinemia
3. Glucose, sulfonylureas, and neurotransmitter release: Role of ATP-sensitive K+ channels
4. Hypothalamic control of food intake in rats and cats
5. The stomach is a source of leptin
6. Hemodynamic actions of insulin
7. In vivo regulation of non-insulin-mediated and insulin-mediated glucose uptake by cortisol
8. In vivo regulation of non-insulin-mediated and insulin-mediated glucose uptake by epinephrine
9. Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity
10. CAP defines a second signalling pathway required for insulin-stimulated glucose transport
11. Hypothalamic hypocretin/orexin and neuropeptide Y: Divergent interaction with energy depletion and leptin
12. ATP-modulated K+ channels sensitive to antidiabetic sulfonylureas are present in adenohypophysis and are involved in growth hormone release
13. The lateral hypothalamic area revisited: Ingestive behavior
14. Brain regions where cholecystokinin suppresses feeding in rats
15. Evidence that suppression of insulin secretion by insulin itself is neurally mediated
16. Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats
17. Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release
18. Mechanisms of the development of obesity in animals with hypothalamic lesions
19. Role of brain insulin receptor in control of body weight and reproduction
20. Effect of insulin on oxidation of intracellularly and extracellularly derived glucose in patients with NIDDM. Evidence for primary defect in glucose transport and/or phosphorylation but not oxidation
21. Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations
22. Hypothalamic orexin expression: Modulation by blood glucose and feeding
23. Forearm muscle insulin resistance during hypoglycemia: Role of adrenergic mechanisms and hypoglycemia per se
24. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: A possible mechanism for leptin resistance
25. The alpha 2-adrenoceptor antagonist efaroxan modulates K+ATP channels in insulin-secreting cells
26. ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 beta-cell line
27. Altered expression of agouti-related protein and its colocalization with neuropeptide Y in the arcuate nucleus of the hypothalamus during lactation
28. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes
29. Counterregulation of hypoglycemia. Skeletal muscle glycogen metabolism during three hours of physiological hyperinsulinemia in humans
30. Sample preparation and radioimmunoassay for circulating free and antibody-bound insulin concentrations in insulin-treated diabetics: A re-evaluation of methods
31. In the ventromedial nucleus of the rat hypothalamus, GABA-immunolabeled neurons are abundant and are innervated by both enkeph
32. The central melanocortin system and energy homeostasis
33. Stimulation of corticotrophin-releasing hormone release by the obese (ob) gene product, leptin, from hypothalamic explants
34. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus
35. Vascular endothelial growth factor: A novel endocrine defensive response to hypoglycemia
36. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay
37. Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids
38. Increased feeding and neuropeptide Y (NPY) but not NPY mRNA levels in the hypothalamus of the rat following central administration of the serotonin synthesis inhibitor p-chlorophenylalanine
39. Distribution and phenotype of neurons containing the ATP-sensitive K+ channel in rat brain
40. Nonadrenergic sympathetic neural influences on basal pancreatic hormone secretion
41. Neuropeptide Y suppresses sympathetic activity to interscapular brown adipose tissue in rats
42. Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity
43. Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area
44. Chemical characterization of leptin-activated neurons in the rat brain
45. Leptin activates hypothalamic CART neurons projecting to the spinal cord
46. Leptin activates neurons in ventrobasal hypothalamus and brainstem
47. Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion
48. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y
49. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young
50. The central melanocortin system can directly regulate serum insulin levels
51. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells
52. Molecular and biological properties of the vascular endothelial growth factor family of proteins
53. Evidence that glucose transport is rate-limiting for in vivo glucose uptake
54. Leptin and the regulation of body weight in mammals
55. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus
56. Comparison of the inhibitory effect of insulin and hypoglycemia on insulin secretion in humans
57. Preserved hypothermic response to hypoglycemia after antecedent hypoglycemia
58. Supraphysiological hyperinsulinemia acutely increases hypothalamic-pituitary-adrenal secretory activity in humans
59. Protective effects of insulin against hypoglycemia-associated counterregulatory failure
60. Leptin affects food intake via CRF-receptor-mediated pathways
61. Central nervous system structures connected with the endocrine glands. Findings obtained with the viral transneuronal tracing technique
62. Blood-barrier glucose transfer
63. Pituitary adenylate cyclase-activating polypeptide, interleukin-6 and glucocorticoids regulate the release of vascular endothelial growth factor in pituitary folliculostellate cells
64. Influence of insulin antibodies on pharmacokinetics and bioavailability of recombinant human and highly purified beef insulins in insulin dependent diabetics
65. Desensitization of beta-adrenergic receptors in adipocytes causes increased insulin sensitivity of glucose transport
66. Glucose uptake, utilization, and signaling in GLUT 2-null islets
67. Involvement of non-esterified fatty acid oxidation in glucocorticoid-induced peripheral insulin resistance in vivo in rats
68. Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons
69. Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons
70. Transcription factor STAT3 in leptin target neurons of the rat hypothalamus
71. PACAP gene expression in neurons of the rat hypothalamo-pituitary-adrenocortical axis is induced by endotoxin and interleukin-1 beta
72. Pituitary adenylate cyclase-activating peptide gene expression in corticotropin-releasing factor-containing parvicellular neurons of the rat hypothalamic paraventricular nucleus is induced by colchicine, but not by adrenalectomy, acute osmotic, ether, or restraint stress
73. No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans
74. Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats
75. The contribution of the autonomic nervous system to changes of glucagon and insulin secretion during hypo-glycemic stress
76. Receptor-mediated regional sympathetic nerve activation by leptin
77. Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress
78. Novel glucosensor for hypoglycemic detection localized to the portal vein
79. Portal vein affernets are critical for the sympathoadrenal response to hypoglycemia
80. The role of TNFalpha and TNF receptors in obesity and insulin resistance
81. Pattern and localisation of expression of vascular endothelial growth factor and its receptor flt-1 in the ovine pituitary gland: Expression is independent of hypo-thalamic control
82. Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues
83. CNS sites involved in sympathetic and parasympathetic control of the pancreas: A viral tracing study
84. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight
85. The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose
86. The adipoinsular axis: Effects of leptin on pancreatic beta-cells
87. Leptin suppression of insulin secretion by the activation of ATP-sensitive K+ channels in pancreatic beta-cells
88. Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone
89. beta(3)-adrenergic stimulation differentially inhibits insulin signaling and decreases insulin-induced glucose uptake in brown adipocytes
90. Glucose transport and metabolism in rat renal proximal tubules: Multicomponent effects of insulin
91. Effects of glycemic control on protective responses against hypoglycemia in type 2 diabetes
92. The effects of the TRH metabolite cyclo(His-Pro) and its analogs on feeding
93. Hypothalamic CART is a new anorectic peptide regulated by leptin
94. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes
95. Upregulation of blood-brain barrier GLUT 1 glucose transporter protein and mRNA in experimental chronic hypoglycemia
96. ATP-sensitive potassium channels: An overview
97. Effects of epinephrine on insulin-stimulated glucose uptake and GLUT4 phosphorylation in muscle
98. Brain glucose sensing and body energy homoestasis: Role in obesity and diabetes
99. Orexin a preferentially excites glucose-sensitive neurons in the lateral hypothalamus of the rat in vitro
100. Changes in BMI and weight before and after the development of type 2 diabetes
101. Towards a molecular understanding of adaptive thermogenesis
102. Leptin actions on food intake and body temperature are mediated by IL-1
103. The hypothalamus, intrinsic connections and outflow pathways to the endocrine system in relation to the control of feeding and metabolism
104. Nonadipose tissue production of leptin: Leptin as a novel placenta-derived hormone in humans
105. Chronic hypoglycemia increases brain glucose transport
106. ATP-sensitive K+ channels in the hypothalamus are essential for the maintenance of glucose homeostasis
107. The structure and function of the ATP-sensitive K+ channel in insulin-secreting pancreatic beta-cells
108. Leptin affects pancreatic endocrine functions through the sympathetic, nervous system
109. Obese gene expression: Reduction by fasting and stimulation by insulin and glucose in lean mice, and persistent elevation in acquired (diet-induced) and genetic (yellow agouti) obesity
110. Evidence that glucose metabolism regulates leptin secretion from cultured rat adipocytes
111. Suppression of insulin-stimulated phosphatidylinositol 3-kinase activity by the beta3-adrenoceptor agonist CL316243 in rat adipocytes
112. Central leptin suppresses splenic lymphocyte functions through activation of the corticotropin-releasing hormone-sympathetic nervous system
113. Evidence of cortisol-related symptom complex (CRSC) in type 2 diabetes. A population based study
114. Glucose inhibition of the glucose-sensitive neurone in the rat lateral hypothalamus
115. Responses of lateral hypothalamic neurons recorded in vitro to moderate changes in glucose concentration
116. Insulin-induced hypoglycaemia increases colocalization of corticotrophin-releasing factor and arginine vasopressin mRNAs in the rat hypothalamic paraventricular nucleus
117. Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor-alpha, but not by insulin
118. TNF-alpha and insulin resistance: Summary and future prospects
119. Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus
120. A role for melanin-concentrating hormone in the central regulation of feeding behaviour
121. Glucose-inhibition of glucagon secretion involves activation of GABAA- receptor chloride channels
122. Physiological insulinemia acutely modulates plasma leptin
123. Sympathetic activation of leptin via the ventromedial hypothalamus: Leptin-induced increase in catecholamine secretion
124. Entrainment of the diurnal rhythm of plasma leptin to meal timing
125. Glucose sensing in pancreatic beta-cells: A model for the study of other glucose-regulated cells in gut, pancreas, and hypothalamus
126. Insulin in the brain: A hormonal regulator of energy balance
127. Identification of targets of leptin action in rat hypothalamus
128. Central nervous system control of food intake
129. The effect of insulin on in vivo cerebral glucose concentrations and rates of glucose transport/metabolism in humans
130. GLUT 1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier
131. Diverse roles of K(ATP) channels learned from Kir6.2 genetically engineered mice
132. Increased epinephrine and skeletal muscle responses to hypoglycemia in non-insulin-dependent diabetes mellitus
133. Change in hexose distribution volume and fractional utilization of [18F]-2-deoxy-2-fluoro-D-glucose in brain during acute hypoglycemia in humans
134. Glucose transporters and insulin action-implications for insulin resistance and diabetes mellitus
135. Mice lacking melanin-concentrating hormone are hypophagic and lean
136. Glucose-induced intracellular ion changes in sugar-sensitive hypothalamic neurons
137. Blood-brain barrier glucose transporter: Effects of hypo- and hyperglycemia revisited
138. Enhancement of glucose transport by vascular endothelial growth factor in retinal endothelial cells
139. Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels
140. Insulin activates ATP-sensitive K+ channels in hypothalamic neurons of lean, but not obese rats
141. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide
142. Hypoglycaemic counter-regulation at normal blood glucose concentrations in patients with well controlled type-2 diabetes
143. Influence of reversible obesity on eating behavior, blood glucose, and insulin in the rat
144. The hormone resistin links obesity to diabetes
145. Important role of the kidney in human carbohydrate metabolism
146. Effects of insulin on vascular tone and sympathetic nervous system in NIDDM
147. The leptin receptor
148. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy
149. Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin
150. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity
151. Roles of circadian rhythmicity and sleep in human glucose regulation
152. Insulin in the arcuate nucleus of the hypothalamus reduces fat consumption in rats
153. Adverse effects of insulin antibodies on postprandial plasma glucose and insulin profiles in diabetic patients without immune insulin resistance. Implications for intensive insulin regimens
154. Effect of hyperketonemia and hyperlacticacidemia on symptoms, cognitive dysfunction, and counterregulatory hormone responses during hypoglycemia in normal humans
155. A nutrient-sensing pathway regulates leptin gene expression in muscle and fat
156. Glucose metabolism rather than insulin is a main determinant of leptin secretion in humans
157. Protective role of ATP-sensitive potassium channels in hypoxia-induced generalized seizure
158. Hypothalamic glucose sensor
159. Localization of rate-limiting defect for glucose disposal in skeletal muscle of insulin-resistant type 1 diabetic patients
160. Kinetics of glucose disposal in whole body and across the forearm in man
161. Positional cloning of the mouse obese gene and its human homologue
162. Leptin inhibits insulin secretion by activation of phosphodiesterase 3B
163. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance